Status:
RECRUITING
Study of Health Behavior in Patients After Heart Valve Replacement： Longitudinal Studies
Lead Sponsor:
Fujian Medical University Union Hospital
Conditions:
Heart Valve Diseases
Health Behavior
Eligibility:
All Genders
18-85 years
Brief Summary
To investigates the influencing factors and the pathways of health behavior in patients after heart valve replacement.
Detailed Description
Currently, the prevalence of heart valve disease is 2.0% to 13.2%, and heart valve replacement is the most important treatment to address heart valve disease. Heart valve replacement surgery is highly...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- VHD diagnosed by echocardiography;
- Received HVR treatment;
- able to communicate normally.
Exclusion
- Those with a conscious disorder or mental illness;
- Those with severe organic diseases or comorbidities;
- Those with cardiac function class IV;
- Those who could not complete the questionnaire correctly independently or under the guidance of the researcher.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT06490952
Start Date
January 1 2024
End Date
December 1 2024
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fujian Medical University Union Hospital
Fuzhou, Fujian, China, 350000